… their safety and therapeutic efficacy against COVID-19. Hence, … and challenges for EVs as
a potential therapeutic agent for … therapeutic potential of MSC derived-EVs against COVID-19-…

… Thus, here, we tried to explain the use of extracellular vesicles as therapeutics and for the
… Finally, we will highlight the issues and associated with developing EVs against COVID-19. …

… great promise for therapeutic treatments, particularly in treating a … of considerable importance
for COVID‐19 patients with acute … EV-based therapies hold great potential for COVID-19–…

… With the recent outbreak of the COVID-19 pandemic, which can cause a wide range of … key
targets for EV-based therapies. Additionally, EVs hold therapeutic promise in addressing axial …

… EVs in COVID-19-generated thrombotic events and the potential of EV-based therapies as a
… will be the next crucial challenge for the development of new therapeutic strategies against …

… proposed for the treatment of coronavirus disease-19 (COVID-19), aiming to … and cell
therapies, presenting exciting opportunities for … to the challenges faced by cell therapies (previously …

… applications and discuss the problems and challenges that have occurred… We have provided
a new metabolic perspective to … among various stages of COVID-19. Their important results …

… There are now clinical trials further evaluating the safety and efficacy of this treatment for
COVID-19 (… Extracellular vesicle-based therapeutics hold the greatest clinical promise when a …

… EVs hold a great promise in acting as drug carriers. The heterogeneity of EVs in term of size
… the COVID-19. However, the benefit and risks in the use of EVs for COVID-19 remain to be …